Top Big Cap Negative News Movers Premarket:  ADBE: -4% Earnings  SMR: -3.5% Downgraded to SELL @ UBS  EXEL: -3% FDA Extended Review Period for Colorectal Cancer Drug 11-SEP-2026 08:03 AM ET